Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $NRC vs $SBC | Chartloom

Compare

$NRC vs $SBC

National Research Corp · SBC Medical Group Holdings Inc

NRC

National Research Corp

SBC

SBC Medical Group Holdings Inc

Compare $NRC vs $SBC

Comparing National Research Corp and SBC Medical Group Holdings Inc

NRCNational Research Corp

SBCSBC Medical Group Holdings Inc

NRCNational Research Corp

Market cap

$452M

P/E (TTM)

81.00x

Forward P/E (NTM)

21.29x

Forward P/S (NTM)

3.04x

Rev growth (TTM)

-0.2%

YTD performance

13.3%

52W performance

78.0%

FCF yield

4.8%

SBCSBC Medical Group Holdings Inc

Market cap

$536M

P/E (TTM)

10.94x

Forward P/E (NTM)

11.06x

Forward P/S (NTM)

2.68x

Rev growth (TTM)

-6.9%

YTD performance

20.8%

52W performance

26.0%

FCF yield

11.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NRC

SBC

Detailed metrics comparison

NRC

National Research Corp

SBC

SBC Medical Group Holdings Inc

Market Cap

NRC$452M

SBC$536M

Enterprise Value

NRC$539M

SBC$390M

Price

NRC$20.43

SBC$5.23

P/E Ratio

NRC81.00x

SBC10.94x

P/S Ratio

NRC3.23x

SBC3.06x

EV/Sales

NRC3.85x

SBC2.23x

EV/EBITDA

NRC23.06x

SBC5.12x

P/B Ratio

NRC68.67x

SBC2.11x

P/FCF Ratio

NRC20.90x

SBC8.84x

EV/FCF

NRC24.91x

SBC6.43x

PEG Ratio

NRCN/A

SBC0.24x

Forward P/E (NTM)

NRC21.29x

SBC11.06x

Forward P/S (NTM)

NRC3.04x

SBC2.68x

Revenue (TTM)

NRC$140M

SBC$175M

Revenue Growth (YoY)

NRC-0.2%

SBC-6.9%

Forward Rev Growth

NRC8.3%

SBC10.2%

Gross Margin (TTM)

NRC61.7%

SBC71.9%

Operating Margin (TTM)

NRC10.5%

SBC37.3%

EBITDA Margin (TTM)

NRC16.7%

SBC39.2%

Net Margin (TTM)

NRC4.0%

SBC28.0%

FCF Margin (TTM)

NRC15.5%

SBC34.7%

Net Income (TTM)

NRC$6M

SBC$49M

FCF (TTM)

NRC$22M

SBC$61M

EPS (TTM)

NRC$0.25

SBC$0.48

ROE (TTM)

NRC48.5%

SBC19.3%

ROA (TTM)

NRC4.3%

SBC13.1%

ROIC (TTM)

NRC6.2%

SBC16.9%

Cash

NRC$3M

SBC$184M

Debt

NRC$90M

SBC$38M

Net Cash/Debt

NRC$-87M

SBC$146M

Current Ratio (TTM)

NRC0.65x

SBC3.31x

Quick Ratio (TTM)

NRC0.50x

SBC3.19x

Debt/Equity (TTM)

NRC13.75x

SBC0.14x

Debt/Assets (TTM)

NRC0.0%

SBC0.0%

Interest Coverage (TTM)

NRCN/A

SBCN/A

Net Debt/EBITDA (TTM)

NRC0.00x

SBC0.00x

Beta

NRC0.26

SBC0.59

52W Performance

NRC78.0%

SBC26.0%

YTD Performance

NRC13.3%

SBC20.8%

% from 52W High

NRC-13.7%

SBC-6.8%

% from 52W Low

NRC85.5%

SBC88.1%

Asset Turnover (TTM)

NRC1.03x

SBC0.47x

FCF Yield (TTM)

NRC4.8%

SBC11.3%

Earnings Yield (TTM)

NRC1.2%

SBC9.1%

Dividend Yield (TTM)

NRC2.8%

SBCN/A

Rule of 40

NRC15.2

SBC27.7

EV/GP/RG

NRC0.98

SBC0.19

Ticker research

View NRC research View SBC research

Metric	NRC National Research Corp	SBC SBC Medical Group Holdings Inc
Market & Valuation
Market Cap	$452M	$536M
Enterprise Value	$539M	$390M
Price	$20.43	$5.23
P/E Ratio	81.00x	10.94x
P/S Ratio	3.23x	3.06x
EV/Sales	3.85x	2.23x
EV/EBITDA	23.06x	5.12x
P/B Ratio	68.67x	2.11x
P/FCF Ratio	20.90x	8.84x
EV/FCF	24.91x	6.43x
PEG Ratio	N/A	0.24x
Forward P/E (NTM)	21.29x	11.06x
Forward P/S (NTM)	3.04x	2.68x
Revenue & Growth
Revenue (TTM)	$140M	$175M
Revenue Growth (YoY)	-0.2%	-6.9%
Forward Rev Growth	8.3%	10.2%
Profitability
Gross Margin (TTM)	61.7%	71.9%
Operating Margin (TTM)	10.5%	37.3%
EBITDA Margin (TTM)	16.7%	39.2%
Net Margin (TTM)	4.0%	28.0%
FCF Margin (TTM)	15.5%	34.7%
Net Income (TTM)	$6M	$49M
FCF (TTM)	$22M	$61M
EPS (TTM)	$0.25	$0.48
ROE (TTM)	48.5%	19.3%
ROA (TTM)	4.3%	13.1%
ROIC (TTM)	6.2%	16.9%
Financial Health
Cash	$3M	$184M
Debt	$90M	$38M
Net Cash/Debt	$-87M	$146M
Current Ratio (TTM)	0.65x	3.31x
Quick Ratio (TTM)	0.50x	3.19x
Debt/Equity (TTM)	13.75x	0.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.26	0.59
52W Performance	78.0%	26.0%
YTD Performance	13.3%	20.8%
% from 52W High	-13.7%	-6.8%
% from 52W Low	85.5%	88.1%
Efficiency & Yields
Asset Turnover (TTM)	1.03x	0.47x
FCF Yield (TTM)	4.8%	11.3%
Earnings Yield (TTM)	1.2%	9.1%
Dividend Yield (TTM)	2.8%	N/A
Other
Rule of 40	15.2	27.7
EV/GP/RG	0.98	0.19
Ticker research	View NRC research	View SBC research

Valuation

P/E Ratio

SBC

10.94x

NRC

81.00x

P/S Ratio

SBC

3.06x

NRC

3.23x

EV/FCF

SBC

6.43x

NRC

24.91x

Growth & revenue

Revenue Growth TTM

NRC

-0.2%

SBC

-6.9%

Forward Revenue Growth

SBC

10.2%

NRC

8.3%

Profitability & performance

Gross Margin

SBC

71.9%

NRC

61.7%

ROE

NRC

48.5%

SBC

19.3%

FCF Yield %

SBC

11.3%

NRC

4.8%

52-Week Performance

NRC

78.0%

SBC

26.0%

Detailed metrics comparison

NRC

National Research Corp

SBC

SBC Medical Group Holdings Inc

Market Cap

NRC$452M

SBC$536M

Enterprise Value

NRC$539M

SBC$390M

Price

NRC$20.43

SBC$5.23

P/E Ratio

NRC81.00x

SBC10.94x

P/S Ratio

NRC3.23x

SBC3.06x

EV/Sales

NRC3.85x

SBC2.23x

EV/EBITDA

NRC23.06x

SBC5.12x

P/B Ratio

NRC68.67x

SBC2.11x

P/FCF Ratio

NRC20.90x

SBC8.84x

EV/FCF

NRC24.91x

SBC6.43x

PEG Ratio

NRCN/A

SBC0.24x

Forward P/E (NTM)

NRC21.29x

SBC11.06x

Forward P/S (NTM)

NRC3.04x

SBC2.68x

Revenue (TTM)

NRC$140M

SBC$175M

Revenue Growth (YoY)

NRC-0.2%

SBC-6.9%

Forward Rev Growth

NRC8.3%

SBC10.2%

Gross Margin (TTM)

NRC61.7%

SBC71.9%

Operating Margin (TTM)

NRC10.5%

SBC37.3%

EBITDA Margin (TTM)

NRC16.7%

SBC39.2%

Net Margin (TTM)

NRC4.0%

SBC28.0%

FCF Margin (TTM)

NRC15.5%

SBC34.7%

Net Income (TTM)

NRC$6M

SBC$49M

FCF (TTM)

NRC$22M

SBC$61M

EPS (TTM)

NRC$0.25

SBC$0.48

ROE (TTM)

NRC48.5%

SBC19.3%

ROA (TTM)

NRC4.3%

SBC13.1%

ROIC (TTM)

NRC6.2%

SBC16.9%

Cash

NRC$3M

SBC$184M

Debt

NRC$90M

SBC$38M

Net Cash/Debt

NRC$-87M

SBC$146M

Current Ratio (TTM)

NRC0.65x

SBC3.31x

Quick Ratio (TTM)

NRC0.50x

SBC3.19x

Debt/Equity (TTM)

NRC13.75x

SBC0.14x

Debt/Assets (TTM)

NRC0.0%

SBC0.0%

Interest Coverage (TTM)

NRCN/A

SBCN/A

Net Debt/EBITDA (TTM)

NRC0.00x

SBC0.00x

Beta

NRC0.26

SBC0.59

52W Performance

NRC78.0%

SBC26.0%

YTD Performance

NRC13.3%

SBC20.8%

% from 52W High

NRC-13.7%

SBC-6.8%

% from 52W Low

NRC85.5%

SBC88.1%

Asset Turnover (TTM)

NRC1.03x

SBC0.47x

FCF Yield (TTM)

NRC4.8%

SBC11.3%

Earnings Yield (TTM)

NRC1.2%

SBC9.1%

Dividend Yield (TTM)

NRC2.8%

SBCN/A

Rule of 40

NRC15.2

SBC27.7

EV/GP/RG

NRC0.98

SBC0.19

Ticker research

View NRC research View SBC research

Metric	NRC National Research Corp	SBC SBC Medical Group Holdings Inc
Market & Valuation
Market Cap	$452M	$536M
Enterprise Value	$539M	$390M
Price	$20.43	$5.23
P/E Ratio	81.00x	10.94x
P/S Ratio	3.23x	3.06x
EV/Sales	3.85x	2.23x
EV/EBITDA	23.06x	5.12x
P/B Ratio	68.67x	2.11x
P/FCF Ratio	20.90x	8.84x
EV/FCF	24.91x	6.43x
PEG Ratio	N/A	0.24x
Forward P/E (NTM)	21.29x	11.06x
Forward P/S (NTM)	3.04x	2.68x
Revenue & Growth
Revenue (TTM)	$140M	$175M
Revenue Growth (YoY)	-0.2%	-6.9%
Forward Rev Growth	8.3%	10.2%
Profitability
Gross Margin (TTM)	61.7%	71.9%
Operating Margin (TTM)	10.5%	37.3%
EBITDA Margin (TTM)	16.7%	39.2%
Net Margin (TTM)	4.0%	28.0%
FCF Margin (TTM)	15.5%	34.7%
Net Income (TTM)	$6M	$49M
FCF (TTM)	$22M	$61M
EPS (TTM)	$0.25	$0.48
ROE (TTM)	48.5%	19.3%
ROA (TTM)	4.3%	13.1%
ROIC (TTM)	6.2%	16.9%
Financial Health
Cash	$3M	$184M
Debt	$90M	$38M
Net Cash/Debt	$-87M	$146M
Current Ratio (TTM)	0.65x	3.31x
Quick Ratio (TTM)	0.50x	3.19x
Debt/Equity (TTM)	13.75x	0.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.26	0.59
52W Performance	78.0%	26.0%
YTD Performance	13.3%	20.8%
% from 52W High	-13.7%	-6.8%
% from 52W Low	85.5%	88.1%
Efficiency & Yields
Asset Turnover (TTM)	1.03x	0.47x
FCF Yield (TTM)	4.8%	11.3%
Earnings Yield (TTM)	1.2%	9.1%
Dividend Yield (TTM)	2.8%	N/A
Other
Rule of 40	15.2	27.7
EV/GP/RG	0.98	0.19
Ticker research	View NRC research	View SBC research